Yüklüyor......
Bispecific T cell engagers for cancer immunotherapy
Bispecific T cell engagers are a new class of immunotherapeutic molecules intended for the treatment of cancer. These molecules, termed BiTEs, enhance the patient’s immune response to tumors by retargeting T cells to tumor cells. BiTEs are constructed of two single chain variable fragments (scFv) co...
Kaydedildi:
| Yayımlandı: | Immunol Cell Biol |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4445461/ https://ncbi.nlm.nih.gov/pubmed/25367186 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/icb.2014.93 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|